View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Jungbunzlauer
6 December 2016

TCC TB: a new filler for direct compression

TCC TB is a tricalcium citrate tetrahydrate designed to function as filler or diluent in tableting and is suitable for usage in direct compression.

The excipient combines exceptional compression characteristics, excellent flowability and good tolerability.TCC TB can be compacted to tablets with high-tensile strength at low-compression forces, while retaining a high-porosity. Tablets produced from TCC TB thereby disintegrate quickly, even without the usage of additional disintegrants.

TCC TB is an ideal addition to low and medium-dose actives. Compared to other brittle fillers like dicalcium phosphates, TCC TB shows a low abrasiveness leading to lower wear on tableting equipment.

TCC TB is produced in a unique production process which creates the special crystalline structure that is responsible for its outstanding characteristics, making it the ideal choice for a direct compression excipient.

Download TCC TB’s free brochure here.

TCC TB is a tricalcium citrate tetrahydrate designed to function as filler or diluent.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology